Welcome. MP Healthcare Venture Management (MPH)
is a Boston-based lifesciences venture capital firm passionate about connecting ideas, technologies, and business processes to create tomorrow’s healthcare innovations. Find out how connecting with MPH can get your ideas to market faster and bring value to your vision. More

News and Events

15 December 2017

QurAlis has won the Amgen Golden Ticket at LabCentral. More

1 October 2017

Ribometrix Raises $7.5M In Seed Funding to Advance Platform for Discovering and Developing Small Molecule Modulators of RNA to Treat Human Diseases. More

6 September 2017

Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer,
Advancing Leadership in Immuno-Oncology. More

4 June 2017

F-star Expands its Relationship with Merck through a new Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology. More

3 May 2017

Rigontec Starts First-In-Human, Phase I/II Trial of RIG-I Agonist
RGT100 and Appoints Eugen Leo as Chief Medical Officer. More

 

 

 

Featured Portfolio